These findings support the existence of a radiogenomic association between imaging features and the aggressive gene expression profile of VSX1, suggesting potential implications for risk stratification and personalized treatment in ccRCC patients (Figure 1). The gene discussed is VSX1; the disease is nonpapillary renal cell carcinoma.